Dihexa vs RG3 (Rhodiola)

Overview

Dihexa and RG3 (Rhodiola) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Dihexa and RG3 (Rhodiola) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Dihexa is categorised under Cognitive Enhancement, while RG3 (Rhodiola) falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Dihexa: not FDA-approved; compounding permitted with a prescription as of April 2026. RG3 (Rhodiola): not FDA-approved; treated as a research compound.

Dosing. Dihexa is typically dosed at Research protocols vary (research). RG3 (Rhodiola) is typically dosed at 3-6 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Dihexa and RG3 (Rhodiola) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Dihexa and RG3 (Rhodiola)?

Dihexa and RG3 (Rhodiola) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas RG3 (Rhodiola) is not FDA-approved; generally classified as a research compound.

What is Dihexa used for?

Potent cognitive enhancer.

What is RG3 (Rhodiola) used for?

Adaptogenic peptide.

Can you take Dihexa and RG3 (Rhodiola) together?

Some users combine peptides within a single protocol, but stacking Dihexa and RG3 (Rhodiola) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Dihexa or RG3 (Rhodiola) FDA-approved?

Dihexa is not FDA-approved; compounding permitted with a prescription (as of April 2026). RG3 (Rhodiola) is not FDA-approved; generally classified as a research compound.